Atencion Primaria最新文献

英文中文

Programa de colaboración Centro de Salud La Jota y farmacéuticos comunitarios del Área de Salud La Jota [La Jota 健康中心与 La Jota 健康区药剂师的跨专业合作计划]。

IF 1.8 4区医学 Q2 MEDICINE, GENERAL & INTERNAL

Atencion Primaria

Pub Date : 2024-10-25 DOI: 10.1016/j.aprim.2024.103110

Ana María Sáez-Benito Suescun , Liliane Mahulea , Laura Gracia Valen , Loreto Sáez-Benito Suescun , Grupo de trabajo Centro de Salud La Jota/Farmacias Comunitarias del Área de Salud La Jota , M. Lourdes Clemente Jiménez

Objective

To assess the feasibility of a collaborative programme among community pharmacies and the health care centre of the area.

Design

Qualitative study.

Site

The collaboration program was implemented at the La Jota Health Care Center and community pharmacies in La Jota.

Participants

The respective professionals from the Health Care Center and the community pharmacies.

Methods

A collaboration program was agreed between the Health Care Center and the pharmacies of La Jota health area. The design of the Program was carried out following the steps of the theoretical framework for the development of Intervention Mapping Pharmaceutical Professional Services. The programme was implemented on March, 2021.

Results

Since the beginning of the program, a total of 16690 electronic prescription renewal messages have been sent. Pharmacists have made 421 visa renewal applications and 394 drug related problems have been notified. The health care centre has sent periodical notifications to community pharmacies for its dissemination among the patients. Satisfaction of all participants is high and the program has been feasible and sustainable in La Jota health area.

Conclusions

This program contributes to solve the serious problems of saturation of primary care, with a high satisfaction of all the agents involved and with an economic investment of zero euros, so it could be implemented in other Basic Health Areas.

目的：评估社区药房与该地区医疗中心合作计划的可行性：评估社区药房与该地区医疗保健中心合作计划的可行性：设计：定性研究。地点：合作计划在拉霍塔医疗保健中心和拉霍塔社区药房实施：参与人员：医疗保健中心和社区药房的相关专业人员：方法：医疗保健中心和 La Jota 健康区的药房商定了一项合作计划。该计划的设计遵循了 "药品专业服务干预映射 "理论框架的发展步骤。该计划于 2021 年 3 月开始实施：自计划开始实施以来，共发送了 16690 条电子处方更新信息。药剂师提出了 421 份续签申请，并通报了 394 个与药物有关的问题。医疗保健中心定期向社区药房发送通知，以便在患者中传播。所有参与者的满意度都很高，该计划在拉霍塔卫生保健区是可行的、可持续的：该计划有助于解决初级保健饱和的严重问题，所有参与人员的满意度都很高，经济投资为零欧元，因此可以在其他基本保健地区实施。

{"title":"Programa de colaboración Centro de Salud La Jota y farmacéuticos comunitarios del Área de Salud La Jota","authors":"Ana María Sáez-Benito Suescun , Liliane Mahulea , Laura Gracia Valen , Loreto Sáez-Benito Suescun , Grupo de trabajo Centro de Salud La Jota/Farmacias Comunitarias del Área de Salud La Jota , M. Lourdes Clemente Jiménez","doi":"10.1016/j.aprim.2024.103110","DOIUrl":"10.1016/j.aprim.2024.103110","url":null,"abstract":"<div><h3>Objective</h3><div>To assess the feasibility of a collaborative programme among community pharmacies and the health care centre of the area.</div></div><div><h3>Design</h3><div>Qualitative study.</div></div><div><h3>Site</h3><div>The collaboration program was implemented at the La Jota Health Care Center and community pharmacies in La Jota.</div></div><div><h3>Participants</h3><div>The respective professionals from the Health Care Center and the community pharmacies.</div></div><div><h3>Methods</h3><div>A collaboration program was agreed between the Health Care Center and the pharmacies of La Jota health area. The design of the Program was carried out following the steps of the theoretical framework for the development of Intervention Mapping Pharmaceutical Professional Services. The programme was implemented on March, 2021.</div></div><div><h3>Results</h3><div>Since the beginning of the program, a total of 16690 electronic prescription renewal messages have been sent. Pharmacists have made 421 visa renewal applications and 394 drug related problems have been notified. The health care centre has sent periodical notifications to community pharmacies for its dissemination among the patients. Satisfaction of all participants is high and the program has been feasible and sustainable in La Jota health area.</div></div><div><h3>Conclusions</h3><div>This program contributes to solve the serious problems of saturation of primary care, with a high satisfaction of all the agents involved and with an economic investment of zero euros, so it could be implemented in other Basic Health Areas.</div></div>","PeriodicalId":55435,"journal":{"name":"Atencion Primaria","volume":"57 4","pages":"Article 103110"},"PeriodicalIF":1.8,"publicationDate":"2024-10-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142513431","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Delays and inequalities in breast cancer in Meta Colombia (2017–2023): A cross-sectional study 梅塔哥伦比亚乳腺癌的延迟和不平等（2017-2023 年）：一项横断面研究。

IF 1.8 4区医学 Q2 MEDICINE, GENERAL & INTERNAL

Atencion Primaria

Pub Date : 2024-10-25 DOI: 10.1016/j.aprim.2024.103116

Cesar Garcia-Balaguera , Mery Gireth Vargas , David Guzmán , Sandra Patricia Ruiz Rodriguez

引用次数: 0

Factibilidad, fiabilidad y validez del cuestionario VIG-express como instrumento de valoración multidimensional/geriátrica rápida: estudio multicéntrico [将 VIG-Express 问卷作为快速多维老年评估工具的可行性、可靠性和有效性：一项多中心研究]。

IF 1.8 4区医学 Q2 MEDICINE, GENERAL & INTERNAL

Atencion Primaria

Pub Date : 2024-10-24 DOI: 10.1016/j.aprim.2024.103108

Núria Gutiérrez Jiménez , Eva Satué-Gracia , Joan Carles Contel , Josep Basora Gallisà , Jordi Amblàs-Novellas

Objective

To evaluate the feasibility, reliability and validity of the VIG-express questionnaire.

Design

Descriptive, observational, cross-sectional and multicenter study.

Setting

Catalonia.

Participants

24 professionals from 18 centers: 10 from Primary Care, 5 from hospitals acute, 2 intermediate care and 3 residential.

Main measurements

For the feasibility analysis, the administration time -mean and standard deviation (SD)-. The questionnaire was administered twice to the same patient by the same professional (intraobserver agreement), or by two different professionals (interobserver agreement), evaluating the intraclass correlation coefficient (ICC). Discriminant validity was calculated by comparing the responses of subgroup with higher fragility (percentile > 75) and subgroup with lower fragility (percentile < 25), for each item of the questionnaire.

Results

195 questionnaires were administered, 59 repeatedly, in a group of elderly (mean age of 79 years) and fragile (mean score of 0.33 in the Fragile Index-VIG). The average administration time was 6.52 minutes (DE: 6.02). The concordance in the degree of fragility score obtained a ICC of 0.95 (intraobserver) and 0.72 (interobserver). In discriminant validity, the differences in response frequencies between the two subgroups ranged from 1.7 (oncological disease) to 67.1 (medication management), all of which were statistically significant (p < 0.05), with the sole exceptions of the presence of oncological and neurological diseases.

Conclusions

The VIG-express questionnaire appears to be a feasible, reliable and valid tool for rapid multidimensional/geriatric assessment.

目的：评估 VIG-express 问卷的可行性、可靠性和有效性：评估 VIG-express 问卷的可行性、可靠性和有效性：描述性、观察性、横断面和多中心研究：参与者：来自 18 个中心的 24 名专业人员：主要测量指标：主要测量指标：可行性分析中的施测时间--平均值和标准差（SD）。由同一专业人员（观察者内部一致）或两名不同专业人员（观察者之间一致）对同一患者进行两次问卷调查，评估类内相关系数（ICC）。通过比较脆性较高的亚组（百分位数大于 75）和脆性较低的亚组（百分位数小于 75）的回答，计算判别效度：对一组老年人（平均年龄 79 岁）和脆性体质者（脆性指数-VIG 平均得分为 0.33）进行了 195 次问卷调查，其中 59 次重复进行。平均发放时间为 6.52 分钟（DE：6.02）。脆性程度评分的 ICC 为 0.95（观察者内）和 0.72（观察者间）。在判别有效性方面，两个亚组之间的回答频率差异从 1.7（肿瘤疾病）到 67.1（药物管理）不等，均具有统计学意义（p 结论：VIG-express 问卷似乎是一种可行、可靠且有效的多维度/老年医学快速评估工具。

{"title":"Factibilidad, fiabilidad y validez del cuestionario VIG-express como instrumento de valoración multidimensional/geriátrica rápida: estudio multicéntrico","authors":"Núria Gutiérrez Jiménez , Eva Satué-Gracia , Joan Carles Contel , Josep Basora Gallisà , Jordi Amblàs-Novellas","doi":"10.1016/j.aprim.2024.103108","DOIUrl":"10.1016/j.aprim.2024.103108","url":null,"abstract":"<div><h3>Objective</h3><div>To evaluate the feasibility, reliability and validity of the VIG-express questionnaire.</div></div><div><h3>Design</h3><div>Descriptive, observational, cross-sectional and multicenter study.</div></div><div><h3>Setting</h3><div>Catalonia.</div></div><div><h3>Participants</h3><div>24 professionals from 18 centers: 10 from Primary Care, 5 from hospitals acute, 2 intermediate care and 3 residential.</div></div><div><h3>Main measurements</h3><div>For the feasibility analysis, the administration time -mean and standard deviation (SD)-. The questionnaire was administered twice to the same patient by the same professional (intraobserver agreement), or by two different professionals (interobserver agreement), evaluating the intraclass correlation coefficient (ICC). Discriminant validity was calculated by comparing the responses of subgroup with higher fragility (percentile >75) and subgroup with lower fragility (percentile <25), for each item of the questionnaire.</div></div><div><h3>Results</h3><div>195 questionnaires were administered, 59 repeatedly, in a group of elderly (mean age of 79 years) and fragile (mean score of 0.33 in the Fragile Index-VIG). The average administration time was 6.52minutes (DE: 6.02). The concordance in the degree of fragility score obtained a ICC of 0.95 (intraobserver) and 0.72 (interobserver). In discriminant validity, the differences in response frequencies between the two subgroups ranged from 1.7 (oncological disease) to 67.1 (medication management), all of which were statistically significant (p<0.05), with the sole exceptions of the presence of oncological and neurological diseases.</div></div><div><h3>Conclusions</h3><div>The VIG-express questionnaire appears to be a feasible, reliable and valid tool for rapid multidimensional/geriatric assessment.</div></div>","PeriodicalId":55435,"journal":{"name":"Atencion Primaria","volume":"57 4","pages":"Article 103108"},"PeriodicalIF":1.8,"publicationDate":"2024-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142513430","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Recomendaciones «No hacer» en el síndrome de fibromialgia [纤维肌痛综合征 "不做 "的建议]。

IF 1.8 4区医学 Q2 MEDICINE, GENERAL & INTERNAL

Atencion Primaria

Pub Date : 2024-10-24 DOI: 10.1016/j.aprim.2024.103115

Javier Ramírez-Gil , Blanca Folch Marín , Patricia Roth Damas , Vicente Palop Larrea

引用次数: 0

Vacunación gripe-COVID-19: juntos, pero no revueltos [流感-COVID-19 疫苗接种：一起接种，但不能混合接种]。

IF 1.8 4区医学 Q2 MEDICINE, GENERAL & INTERNAL

Atencion Primaria

Pub Date : 2024-10-22 DOI: 10.1016/j.aprim.2024.103107

Ana Pilar Javierre Miranda , Susana Martín Martín , José Javier Gómez Marco

引用次数: 0

Los problemas del tutor MIR siguen esperando solución [MIR 导师的问题仍有待解决]。

IF 1.8 4区医学 Q2 MEDICINE, GENERAL & INTERNAL

Atencion Primaria

Pub Date : 2024-10-19 DOI: 10.1016/j.aprim.2024.103122

Amando Martín Zurro

引用次数: 0

Signos cutáneos «sincrónicos» clásicos en una paciente con dermatomiositis amiopática [一名肌病性皮肌炎患者的典型同步皮肤症状］

IF 1.8 4区医学 Q2 MEDICINE, GENERAL & INTERNAL

Atencion Primaria

Pub Date : 2024-10-19 DOI: 10.1016/j.aprim.2024.103111

Hilayali Aguilar-Molina , Daniel Manzur-Sandoval

引用次数: 0

Impact of COVID-19 on the prevalence of dyslipidemia in Ecuador: A cross-sectional study between 2017 and 2022 COVID-19 对厄瓜多尔血脂异常患病率的影响：2017年至2022年横断面研究。

IF 1.8 4区医学 Q2 MEDICINE, GENERAL & INTERNAL

Atencion Primaria

Pub Date : 2024-10-18 DOI: 10.1016/j.aprim.2024.103007

Josue Rivadeneira , Luis Fuenmayor-González , Michelle Jácome-García , Nancy Flores-Lastra , Hugo Delgado , Tamara Otzen

Objective

To determine changes in the prevalence of dyslipidemias during the pre-COVID-19 and COVID-19 years in three regions of Ecuador.

Design

Cross-sectional study.

Site

Quito, Guayaquil, and El Coca.

Participants

Adults with cholesterol, HDL, LDL, and triglyceride levels at primary care centers from January 2017 to December 2022.

Interventions

Not applicable.

Main measurements

Data were obtained from five BIODIMED primary care centers. Cholesterol, HDL, LDL, and triglyceride levels were classified according to the ATP III guidelines. Dyslipidemia was considered present when one or more parameters exceeded specific thresholds. Sociodemographic variables and the year of examination were included as independent variables.

Results

The study analyzed 110,521 participants’ laboratory results, where 65.3% were males and an average age of 38 ± 12 years. The study spanned the Andean (72.4%), Coast (15.4%), and Amazonic region (12.3%). Pre-pandemic exams constituted 60.9% of the sample. The prevalence of dyslipidemia increased gradually from 43.1% in 2017 to 64.1% in 2022. Cholesterol levels, HDL, and LDL exhibited changes during the pandemic, with an increased risk of hypercholesterolemia, low HDL, and high LDL.

Conclusions

During the COVID-19 pandemic, a notable increase in the prevalence of dyslipidemias, including hypercholesterolemia, high triglycerides, and high LDL, was determined across three regions in Ecuador.

目的：确定厄瓜多尔三个地区在 COVID-19 前和 COVID-19 期间血脂异常发生率的变化：确定厄瓜多尔三个地区在 COVID-19 之前和 COVID-19 期间血脂异常患病率的变化情况：设计：横断面研究。研究地点基多、瓜亚基尔和埃尔科卡：2017年1月至2022年12月在初级保健中心检测胆固醇、高密度脂蛋白、低密度脂蛋白和甘油三酯水平的成年人：不适用：数据来自五个BIODIMED初级保健中心。根据 ATP III 指南对胆固醇、高密度脂蛋白、低密度脂蛋白和甘油三酯水平进行分类。当一个或多个参数超过特定阈值时，即认为存在血脂异常。社会人口学变量和检查年份被列为自变量：研究分析了 110 521 名参与者的化验结果，其中 65.3% 为男性，平均年龄为 38±12 岁。研究范围包括安第斯地区（72.4%）、沿海地区（15.4%）和亚马逊地区（12.3%）。大流行前体检者占样本的 60.9%。血脂异常患病率从2017年的43.1%逐渐上升到2022年的64.1%。胆固醇水平、高密度脂蛋白和低密度脂蛋白在大流行期间发生了变化，高胆固醇血症、低高密度脂蛋白和高低密度脂蛋白的风险增加：结论：在 COVID-19 大流行期间，厄瓜多尔三个地区的血脂异常（包括高胆固醇血症、高甘油三酯和高低密度脂蛋白）患病率明显增加。

{"title":"Impact of COVID-19 on the prevalence of dyslipidemia in Ecuador: A cross-sectional study between 2017 and 2022","authors":"Josue Rivadeneira , Luis Fuenmayor-González , Michelle Jácome-García , Nancy Flores-Lastra , Hugo Delgado , Tamara Otzen","doi":"10.1016/j.aprim.2024.103007","DOIUrl":"10.1016/j.aprim.2024.103007","url":null,"abstract":"<div><h3>Objective</h3><div>To determine changes in the prevalence of dyslipidemias during the pre-COVID-19 and COVID-19 years in three regions of Ecuador.</div></div><div><h3>Design</h3><div>Cross-sectional study.</div></div><div><h3>Site</h3><div>Quito, Guayaquil, and El Coca.</div></div><div><h3>Participants</h3><div>Adults with cholesterol, HDL, LDL, and triglyceride levels at primary care centers from January 2017 to December 2022.</div></div><div><h3>Interventions</h3><div>Not applicable.</div></div><div><h3>Main measurements</h3><div>Data were obtained from five BIODIMED primary care centers. Cholesterol, HDL, LDL, and triglyceride levels were classified according to the ATP III guidelines. Dyslipidemia was considered present when one or more parameters exceeded specific thresholds. Sociodemographic variables and the year of examination were included as independent variables.</div></div><div><h3>Results</h3><div>The study analyzed 110,521 participants’ laboratory results, where 65.3% were males and an average age of 38±12 years. The study spanned the Andean (72.4%), Coast (15.4%), and Amazonic region (12.3%). Pre-pandemic exams constituted 60.9% of the sample. The prevalence of dyslipidemia increased gradually from 43.1% in 2017 to 64.1% in 2022. Cholesterol levels, HDL, and LDL exhibited changes during the pandemic, with an increased risk of hypercholesterolemia, low HDL, and high LDL.</div></div><div><h3>Conclusions</h3><div>During the COVID-19 pandemic, a notable increase in the prevalence of dyslipidemias, including hypercholesterolemia, high triglycerides, and high LDL, was determined across three regions in Ecuador.</div></div>","PeriodicalId":55435,"journal":{"name":"Atencion Primaria","volume":"57 4","pages":"Article 103007"},"PeriodicalIF":1.8,"publicationDate":"2024-10-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142481602","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Desafíos y oportunidades: la telemedicina en la práctica sanitaria actual 挑战与机遇：当今医疗实践中的远程医疗

IF 1.8 4区医学 Q2 MEDICINE, GENERAL & INTERNAL

Atencion Primaria

Pub Date : 2024-10-16 DOI: 10.1016/j.aprim.2024.102991

Paula Ramos Floro , Rosario Salas

引用次数: 0

Necesidades formativas de los médicos de atención primaria respecto al deseo de adelantar la muerte 初级保健医生在希望提前死亡方面的培训需求

IF 1.8 4区医学 Q2 MEDICINE, GENERAL & INTERNAL

Atencion Primaria

Pub Date : 2024-10-16 DOI: 10.1016/j.aprim.2024.103050

Joaquim Julià-Torras , Cristina Monforte-Royo , Andrea Rodríguez-Prat , Albert Balaguer

引用次数: 0

首页上一页

下一页尾页

类型

全部化学•材料生命科学医学物理工程技术环境•农林材料科学地球科学法学管理学化学环境科学与生态学计算机科学教育学经济学农林科学人文科学生物学数学物理与天体物理心理学综合性期刊其他工业工程理学历史学农学文学信息工程

数据库

全部 ACS Publications Elsevier ieeexplore Springer The Royal Society of Chemistry Wiley

期刊

Atencion Primaria

全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.

﹀